« Return to News | R&D Trends

China to spend billions on biotech development

Tuesday, July 5, 2011 12:27 PM

China will spend $308.5 billion on science and technology, making biotechnology a major priority in the next five years, said Chinese State Councilor Liu Yandong, according to China Daily. 

The Chinese government will work to further combine biotechnology with economic development and with improving ordinary people's livelihoods, Liu said. 

In the next five years, China will use biotechnology to prevent disasters or alleviate the harm caused by them, protect the environment, employ "green" construction methods and control climate change. Meanwhile, the latest innovations in biotechnology should be relied on to guarantee domestic standards are met for nutrition, hygiene, healthcare, food and drug safety and disease diagnosis and prevention, Liu stressed. 

During the 12th Five-Year Plan period, the Chinese government will spend money on innovative medicine, the cultivation of new varieties of genetically modified organisms and the prevention and control of viral hepatitis and other infectious diseases, according to Ma Hongjian, deputy director of the China National Center for Biotechnology Development. 

Biotechnology has become a strategic pillar industry for China. From 2011 to 2015, it is expected to generate one million jobs, extend people's life expectancies by one year and reduce the infant mortality rate to 12%, as well as reduce emissions of the most common pollutants by 10%, Ma said.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.